Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Ultragenyx Pharmaceutical (RARE) Asset Utilization Ratio: 2017-2025

Historic Asset Utilization Ratio for Ultragenyx Pharmaceutical (RARE) over the last 8 years, with Sep 2025 value amounting to 0.51.

  • Ultragenyx Pharmaceutical's Asset Utilization Ratio rose 52.53% to 0.51 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.51, marking a year-over-year increase of 52.53%. This contributed to the annual value of 0.37 for FY2024, which is 30.82% up from last year.
  • Ultragenyx Pharmaceutical's Asset Utilization Ratio amounted to 0.51 in Q3 2025, which was up 8.38% from 0.47 recorded in Q2 2025.
  • In the past 5 years, Ultragenyx Pharmaceutical's Asset Utilization Ratio registered a high of 0.51 during Q3 2025, and its lowest value of 0.20 during Q1 2021.
  • In the last 3 years, Ultragenyx Pharmaceutical's Asset Utilization Ratio had a median value of 0.33 in 2024 and averaged 0.36.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first spiked by 93.45% in 2021, then dropped by 2.61% in 2022.
  • Ultragenyx Pharmaceutical's Asset Utilization Ratio (Quarterly) stood at 0.23 in 2021, then fell by 1.73% to 0.23 in 2022, then soared by 38.56% to 0.32 in 2023, then grew by 15.75% to 0.37 in 2024, then spiked by 52.53% to 0.51 in 2025.
  • Its Asset Utilization Ratio was 0.51 in Q3 2025, compared to 0.47 in Q2 2025 and 0.42 in Q1 2025.